Paper17575233
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis.
Wilkinson RW and 18 others. Clin Cancer Res, 2007. Cited by 311 papers, by iCite.
Cite this record
ConductScience Library. AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Papers, record 17575233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17575233
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Apoptosis | Major topic |
| Neoplasms, Experimental | Major topic |
| Organophosphates | Major topic |
| Quinazolines | Major topic |
| Animals | |
| Aurora Kinase B | |
| Aurora Kinases | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Flow Cytometry | |
| Humans | |
| Mice | |
| Mice, Nude | |
| Protein Serine-Threonine Kinases | |
| Rats | |
| Transplantation, Heterologous |
Source PubMed
Cited by164
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 311 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42028206 | Discovery of thieno[2,3-d]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model. | RSC Adv | 2026 | https://conductscience.org/library/papers/42028206 | PubMed |
| 41813673 | Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors. | Nat Commun | 2026 | https://conductscience.org/library/papers/41813673 | PubMed |
| 41540256 | Chromosome length is constrained by spindle scaling to ensure faithful mitosis in mammals. | Mol Syst Biol | 2026 | https://conductscience.org/library/papers/41540256 | PubMed |
| 41357898 | Structure-based identification of Jervine as a potent dual-targeting inhibitor of cell cycle kinases. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41357898 | PubMed |
| 41159445 | KLHL13 functional defects cause neurodevelopmental disorder in humans that can be rescued via inhibition of AURKB in cellular and animal models. | Genet Med | 2026 | https://conductscience.org/library/papers/41159445 | PubMed |
| 41089486 | Discovery of a Potent and Highly Selective Inhibitor of Aurora A Kinase. | ACS Med Chem Lett | 2025 | https://conductscience.org/library/papers/41089486 | PubMed |
| 41037662 | Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities. | Cancer Discov | 2026 | https://conductscience.org/library/papers/41037662 | PubMed |
| 40822359 | AURKB and PI3K/AKT/mTOR pathways converge to regulate TERT expression. | iScience | 2025 | https://conductscience.org/library/papers/40822359 | PubMed |
| 40740243 | The Traditional Chinese Medicine Formula Modified Wu Bao San Induces Cell Cycle Arrest and Apoptosis through Restoration of Retinoblastoma Protein Function and Inhibition of Aurora Kinase Activity. | J Cancer | 2025 | https://conductscience.org/library/papers/40740243 | PubMed |
| 40481349 | The expression and prognosis for Aurora kinases in human non-small cell lung cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40481349 | PubMed |
| 39933527 | Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studies. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/39933527 | PubMed |
| 39932274 | Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial Carcinoma. | Cancer Res Commun | 2025 | https://conductscience.org/library/papers/39932274 | PubMed |
| 39073155 | Haspin mediates H3.3S31 phosphorylation downstream of Aurora B in mouse embryonic stem cells. | Protein Sci | 2024 | https://conductscience.org/library/papers/39073155 | PubMed |
| 38315003 | Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy. | Cancer Discov | 2024 | https://conductscience.org/library/papers/38315003 | PubMed |
| 37443114 | BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37443114 | PubMed |
| 37289191 | Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer. | Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37289191 | PubMed |
| 37230964 | An Aurora B-RPA signaling axis secures chromosome segregation fidelity. | Nat Commun | 2023 | https://conductscience.org/library/papers/37230964 | PubMed |
| 36902447 | Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902447 | PubMed |
| 36515566 | A theory of rapid evolutionary change explaining the de novo appearance of megakaryocytes and platelets in mammals. | J Cell Sci | 2022 | https://conductscience.org/library/papers/36515566 | PubMed |
| 36497287 | The Aurora Kinase Inhibitor TAK901 Inhibits Glioblastoma Growth by Blocking SREBP1-Mediated Lipid Metabolism. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36497287 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AURKB | 9212 | PubTator's text mining | https://conductscience.org/library/genes/9212 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17575233
GET https://conductscience.org/api/papers/v1/17575233/cited_by?page=2